Guest, the 'News in Brief' for the week beginning 29th May 2023 is here.Dismiss Notice
Welcome! To read the Core Purpose and Values of our forum, click here.Dismiss Notice
Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study - 2020 - Rekeland, Mella, Fluge et al
published in frontiers in Medicine - Family Medicine and Primary Care Results: The overall response rate by Fatigue score was 55.0% (22 of 40...